Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Fluorouracil")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 6769

  • Page / 271
Export

Selection :

  • and

5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compoundATTILA, Can; UEDA, Akihiro; WOOD, Thomas K et al.Applied microbiology and biotechnology. 2009, Vol 82, Num 3, pp 525-533, issn 0175-7598, 9 p.Article

5-Fluorouracil superficial peel for multiple actinic keratosesBAGATIN, Ediléia; TEIXEIRA, Solange P; HASSUN, Karime M et al.International journal of dermatology. 2009, Vol 48, Num 8, pp 902-907, issn 0011-9059, 6 p.Article

5-Fluorouracil Induced Hyperammonemic Encephalophathy: Etiopathologic CorrelationDE LAPISCINA, Elena Hernández Martínez; ERRO AGUIRRE, María Elena; GIADAS, Teresa Cabada et al.Canadian journal of neurological sciences. 2012, Vol 39, Num 4, pp 553-554, issn 0317-1671, 2 p.Article

A NEW APPROACH TO THE DEVELOPMENT OF ANTI-CANCER AGENTS-5-FU DERIVATIVES.OKADA T; NAKAYAMA M; MITSUI R et al.1974; HIROSHIMA J. MED. SCI.; JAP.; DA. 1974; VOL. 23; NO 2-3; PP. 51-76; BIBL. 19 REF.Article

Effect of biological time on the determination of the LD50 of 5-fluorouracil in miceBURNS, E. R; BELAND, S. S.Pharmacology. 1984, Vol 28, Num 5, pp 296-300, issn 0031-7012Article

Fluorouracil Cream 0.5% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label StudySTOUGH, Dow; BUCKO, Alicia D; VAMVAKIAS, George et al.Cutis (New York, NY). 2010, Vol 85, Num 5, pp 267-273, issn 0011-4162, 7 p.Article

ATR-Chk1 signaling pathway and homologous recombinational repair protect cells from 5-fluorouracil cytotoxicityFUJINAKA, Yoshihiko; MATSUOKA, Kazuaki; YAMAMOTO, Ken-Ichi et al.DNA repair. 2012, Vol 11, Num 3, pp 247-258, issn 1568-7864, 12 p.Article

YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) geneSTEIN, Ulrike; BERGMANN, Stephan; SCHEFFER, George L et al.Oncogene (Basingstoke). 2005, Vol 24, Num 22, pp 3606-3618, issn 0950-9232, 13 p.Article

Identification of phosphorylated serine-15 and -82 residues of HSPB1 in 5-fluorouracil-resistant colorectal cancer cells by proteomicsSAKAI, Akiko; OTANI, Mieko; MIYAMOTO, Akiko et al.Journal of proteomics (Print). 2012, Vol 75, Num 3, pp 806-818, issn 1874-3919, 13 p.Article

Bases biologiques des associations chimio-radiothérapies = Biological basis of chemo-radiotherapy associationsHENNEQUIN, C; QUERO, L; FAVAUDON, V et al.Revue des maladies respiratoires actualités (Print). 2010, Vol 2, Num 3, pp 176-179, issn 1877-1203, 4 p.Conference Paper

Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell linesOKA, Hiroaki; IKEDA, Kazumasa; YOSHIMURA, Hiromi et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2006, Vol 606, Num 1-2, pp 52-60, issn 1383-5718, 9 p.Article

Assay and time course of 5-fluorouracil incorporation into RNA of L1210/0 ascites cells in vivoSPEARS, C. P; JASHOVAM SHANI; SHAHINIAN, A. H et al.Molecular pharmacology. 1985, Vol 27, Num 2, pp 302-307, issn 0026-895XArticle

High prevalence of the IVS14 + 1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicityVAN KUILENBURG, André B. P; MEINSMA, Rutger; ZOETEKOUW, Lida et al.Pharmacogenetics (London). 2002, Vol 12, Num 7, pp 555-558, issn 0960-314X, 4 p.Article

Polymer drugs and polymeric drugs. IX. Synthesis and 5-fluorouracil release profiles of biodegradable polymeric prodrugs γ-poly(α-hydroxymethyl-5 -fluorouracil-glutamate)KISHIDA, A; GOTO, H; MURAKAMI, K et al.Journal of bioactive and compatible polymers. 1998, Vol 13, Num 3, pp 222-233, issn 0883-9115Article

The new fluor-hydroxy pulse peel : A combination of 5-fluorouracil and glycolic acid. CommentaryMARRERO, G. M; KATZ, B. E; OTLEY, C. C et al.Dermatologic surgery. 1998, Vol 24, Num 9, pp 973-978, issn 1076-0512Article

Effectiveness of 5-fluorouracil treatment for actinic keratosis -a systematic review of randomized controlled trialsASKEW, Deborah A; MICKAN, Sharon M; SOYER, H. Peter et al.International journal of dermatology. 2009, Vol 48, Num 5, pp 453-463, issn 0011-9059, 11 p.Article

An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamstersMORVAN, Frédéric O; BAROUKH, Brigitte; LEDOUX, Dominique et al.The American journal of pathology. 2004, Vol 164, Num 2, pp 739-746, issn 0002-9440, 8 p.Article

Biochemical Modulation: Its Pharmacological Basis and Clinical ApplicationsLOW CHENG HOCK.Oncology. 1997, Vol 54, issn 0030-2414, 42 p., SUP1Conference Proceedings

19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridineHOLLAND, S. K; BERGMAN, A. M; ZHAO, Y et al.Magnetic resonance in medicine. 1997, Vol 38, Num 6, pp 907-916, issn 0740-3194Article

Prodrugs of 5-fluorouracil. IV: Hydrolysis kinetics, bioactivation and physicochemical properties of various N-acyloxymethyl derivatives of 5-fluorouracilBUUR, A; BUNDGAARD, H; FALCH, E et al.International journal of pharmaceutics. 1985, Vol 24, Num 1, pp 43-60, issn 0378-5173Article

Increased levels of thymidylate synthetase in cells exposed to 5-fluorouacilWASHTIEN, W. L.Molecular pharmacology. 1984, Vol 25, Num 1, pp 171-177, issn 0026-895XArticle

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancerCRANE, Christopher H; SKIBBER, John M; LOCKETT, Mary Ann et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 84-89, issn 0360-3016, 6 p.Article

Tumor treatment by sustained intratumoral release of 5-fluorouracil: Effects of drug alone and in combined treatmentsBERRADA, Mohammed; ZHI YANG; LEHNERT, Shirley et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1550-1557, issn 0360-3016, 8 p.Article

Maculopapular eruption resulting from systemic administration of 5-fluorouracilREED, W. P; MORRIS, D. M.Cutis (New York, NY). 1984, Vol 33, Num 4, pp 381-382, issn 0011-4162Article

ANTITUMOR ACTIVITY OF BENZOYL AND BENZENESULFONYL DERIVATIVES OF 5-FLUOROURACILHOSHI A; IIGO M; NAKAMURA N et al.1974; GANN; JAP.; DA. 1974; VOL. 65; NO 5; PP. 463Article

  • Page / 271